ethyl loflazepate has been researched along with Neurotic Disorders in 1 studies
ethyl loflazepate: structure given in first source
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The therapeutic efficacy on several neuroses between CM6912 and diazepam (DZP) was comparatively investigated by means of intergroup comparison method in a double-blind trials." | 9.06 | Comparison of therapeutic efficacy of neuroses between CM6912 (ethyl loflazepate) and diazepam in a double-blind trial. ( Hada, Y; Hasegawa, K; Jinbo, S; Kamijima, K; Mori, A; Murasaki, M; Noguchi, T, 1989) |
| " The therapeutic efficacy on several neuroses between CM6912 and diazepam (DZP) was comparatively investigated by means of intergroup comparison method in a double-blind trials." | 5.06 | Comparison of therapeutic efficacy of neuroses between CM6912 (ethyl loflazepate) and diazepam in a double-blind trial. ( Hada, Y; Hasegawa, K; Jinbo, S; Kamijima, K; Mori, A; Murasaki, M; Noguchi, T, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murasaki, M | 1 |
| Mori, A | 1 |
| Noguchi, T | 1 |
| Hada, Y | 1 |
| Hasegawa, K | 1 |
| Jinbo, S | 1 |
| Kamijima, K | 1 |
1 trial available for ethyl loflazepate and Neurotic Disorders
| Article | Year |
|---|---|
Comparison of therapeutic efficacy of neuroses between CM6912 (ethyl loflazepate) and diazepam in a double-blind trial.
Topics: Anti-Anxiety Agents; Anxiety; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic; Diazepam | 1989 |